Correlation Between Regeneron Pharmaceuticals and Biomet

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Biomet at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Biomet into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Biomet Inc, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Biomet and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Biomet. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Biomet.

Diversification Opportunities for Regeneron Pharmaceuticals and Biomet

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Regeneron and Biomet is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Biomet Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomet Inc and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Biomet. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomet Inc has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Biomet go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Biomet

If you would invest (100.00) in Biomet Inc on September 21, 2024 and sell it today you would earn a total of  100.00  from holding Biomet Inc or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  Biomet Inc

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Biomet Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomet Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Biomet is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Regeneron Pharmaceuticals and Biomet Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and Biomet

The main advantage of trading using opposite Regeneron Pharmaceuticals and Biomet positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Biomet can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomet will offset losses from the drop in Biomet's long position.
The idea behind Regeneron Pharmaceuticals and Biomet Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance